Enovis Corporation (ENOV) Investor Relations Documents

Enovis Corporation (ENOV) investor relations documents from the company's IR site: 1 presentation, 10 press releases; latest deck 2026-05-07. Read in-app with summaries. First-party data.

Q1 2026 Earnings Presentation — Enovis Q1 2026 results show 3% organic sales growth and 6% growth adjusted for selling days, with the company reaffirming its full-year 2026 financial guidance.

Investor relations documents — source: company IR site
PublishedTypeDocument
2026-08-06Press releaseEnovis Announces Second Quarter 2026 Results
2026-07-17Press releaseEnovis to Host Second Quarter 2026 Results Conference Call on August 6th
2026-07-13Press releaseEnovis™ Companion Animal Health Launches CT-RevitL™, the Next-Generation Laser Therapy System for Veterinary Care
2026-06-08Press releaseEnovis Launches Spinamic® Hybrid Scoliosis Brace, Combining Corrective Performance with Improved Wearability for Childre
2026-05-07Earnings deckQ1 2026 Earnings Presentation
2026-05-07Press releaseRead more
2026-04-10Press releaseEnovis to Host First Quarter 2026 Results Conference Call on May 7th
2026-02-26Press releaseEnovis Announces Fourth Quarter and Full Year 2025 Results
2026-02-03Press releaseEnovis to Participate in the BTIG 13th Annual MedTech, Digital Health, Life Science & Diagnostic Tools Conference
2026-01-23Press releaseEnovis to Host Fourth Quarter and Full Year 2025 Results Conference Call on February 26th
2026-01-08Press releaseEnovis to Participate in the 44th Annual J.P. Morgan Healthcare Conference

ENOV overview · ENOV earnings · ENOV financials · ENOV KPIs · ENOV ownership · ENOV peers · ENOV filings

Documents published by the company on its investor-relations site; summaries are model-written. Not personalized investment advice.